Stock MYGN MYRIAD GENETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Myriad Genetics, Inc.

Equities

MYGN

US62855J1043

Market Closed - Nasdaq
Other stock markets
 16:00:08 2024-05-17 EDT 		5-day change 1st Jan Change
25.31 USD +2.84% Intraday chart for Myriad Genetics, Inc. -0.63% +32.24%
05-13 Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating MT
05-08 Sector Update: Health Care Stocks Softer Late Afternoon MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Diagnostic & Testing Substances

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
 2.29B -
BIOMÉRIEUX Stock bioMérieux
 12.32B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
 8.07B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
 5.91B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
 5.52B - -
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
 4.21B
  1. Stock Market
  2. Equities
  3. MYGN Stock
  4. Charts Myriad Genetics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW